Evidence map›Paper›PMID 38633613›Full record

ArticleFrontiers in pharmacology2024

Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma.

Jian Wang, Zhilong Zhang, Qian Li, Zilong Hu, Yuan Chen, Hao Chen, Wei Cai, Qiancheng Du, Peng Zhang, Dian Xiong and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Plants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jian Wang *Department of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Zhilong Zhang *Department of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Qian Li *Department of General Practice, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Zilong HuDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Yuan ChenDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Hao ChenDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Wei CaiDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Qiancheng DuDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Peng ZhangDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Dian XiongDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Shugao YeDepartment of Thoracic Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Shanghai Xuhui Central Hospital · CNNanchang University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell cycle arrestcurcuminesophageal squamous cell carcinomamolecular dockingnetwork pharmacology

Identifiers

PMID38633613
PMCPMC11021710
OpenAlexW4393900585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.